Valion Bio
VBIO
8 hedge funds and large institutions have $241K invested in Valion Bio in 2024 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, reducing their positions, and 0 closing their positions.
187% more capital invested
Capital invested by funds: $83.8K → $241K (+$157K)
167% more funds holding
Funds holding: 3 → 8 (+5)
5.43% more ownership
Funds ownership: 4.58% → 10.01% (+5.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCC
Cable Car Capital
San Francisco,
California
|
+$207K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$80.9K |
| 3 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
+$59.2K |
| 4 |
VF
Virtu Financial
New York
|
+$31.2K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$17.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$14 |
VBIO Hedge Fund Activity: Q2 2024 in Review
8 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Valion Bio (VBIO) for Q2 2024, worth a combined $241K — up 187% from $83.8K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new VBIO positions and 0 closed out — a net gain of 5 holders — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Cable Car Capital, opening a new position worth an estimated $207K. The largest seller was Wells Fargo, cutting an estimated $14.
- 8 institutional investors held Valion Bio (VBIO) as of Q2 2024, up from 3 in Q1 2024.
- Funds reported $241K of Valion Bio stock for Q2 2024, up 187% quarter-over-quarter.
- 5 funds opened new Valion Bio positions in Q2 2024 and 0 closed out, a net change of +5 holders.
- The largest Valion Bio buyer in Q2 2024 was Cable Car Capital, an estimated $207K added.
- The largest Valion Bio seller in Q2 2024 was Wells Fargo, an estimated $14 sold.
Based on aggregated 13F filings for Q2 2024.